The Skin Cancer Foundation – Destination: Healthy Skin
Destination: Healthy Skin, The Skin Cancer Foundation’s mobile skin cancer education and screening program concluded its second annual journey around the U.S.
Local volunteer dermatologists conducted 1,243 free skin cancer screenings aboard the Foundation’s 38-foot Destination: Healthy Skin RV. Program participants also received The Skin Cancer Foundation’s educational materials and Wal …
Destination: Healthy Skin, The Skin Cancer Foundation’s mobile skin cancer education and screening program concluded its second annual journey around the U.S.
Local volunteer dermatologists conducted 1,243 free skin cancer screenings aboard the Foundation’s 38-foot Destination: Healthy Skin RV. Program participants also received The Skin Cancer Foundation’s educational materials and Wal … Continue reading "The Skin Cancer Foundation – Destination: Healthy Skin"
Have you received your September JDD issue yet? The Special Focus of this month's issue is Aesthetics. Below are the highlights for the September issue!
Highlights:
Topical EGF is a safe, noninvasive, and effective in A Randomized, Double-
Blind, Placebo-Controlled, Split-Face Study of the Efficacy of Topical
Epidermal Growth Factor for the Treatment of Melasma.
The fourth in a ser … 
Case Report and Pearls for Accurate Diagnosis – An Interview with the Author
During the 2018 Skin of Color Seminar Series (now the Skin of Color Update), approximately twenty posters could be seen hanging in the poster viewing area. Each of these posters highlights novel and exciting research in skin of color. In one such poster, Dr. Monica Huynh and colleagues presented a case of the skin co … 
All of the most commonly used general dermatology texts start out with the basic science of skin, with good reason.
Understanding the function of important molecules and molecular structures is key to understanding many dermatologic disorders. For that reason, the correlation between pathophysiology and clinical findings make this topic a favorite for second and third-order questions on the b … 
A patient on sorafenib for renal cancer asks what side effect she is most likely to experience?
A.). Hypertrichosis
B.) Nevi changes
C.) Q-T prolongation
D.) Cystitis after the first month
E.) Redness and tender blisters at sites of pressure on the hands and feet
To find out the correct answer and read the explanation click here
Brought to you by our Brand …